ISRG250103P545000
- 24.55
- 0.000.00%
Intuitive Surgical Newsroom
Morgan Stanley strongly recommends the three major gold stocks in Medical Technology for 2025: Boston Scientific (BSX.US), Intuitive Surgical (ISRG.US), and Insulet (PODD.US).
JPMorgan selected Boston Scientific and Intuitive Surgical as its preferred Large Cap stocks in the Medical Technology sector in its New Year report, and reaffirmed its favor for the insulin pump manufacturer Insulet in the mid-cap Medical Technology sector.
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Here Are J. P. Morgan's Top MedTech Picks for 2025
Intuitive Surgical Promotes Charlton, Samath, Loeb As EVPs
Street Color: Intuitive Promotes Jamie Samath to CFO
Express News | Intuitive Surgical Inc - Jamie Samath Promoted to CFO
Press Release: Intuitive Announces Executive Leadership Changes to Support Continued Global Growth
Supported by NVIDIA and Tesla! The Global robotics market may experience a major explosion, and these Concept stocks are likely to take off.
Jensen Huang once exclaimed, "The era of Siasun Robot&Automation is about to arrive."
Intuitive Announces Executive Leadership Changes to Support Continued Global Growth
Evercore Maintains Intuitive Surgical(ISRG.US) With Hold Rating, Raises Target Price to $530
CICC Initiates Intuitive Surgical at Neutral With $550 Price Target
Will Intuitive Surgical (ISRG) Beat Estimates Again in Its Next Earnings Report?
If You Invested $100 In This Stock 10 Years Ago, You Would Have This Much Today
Intuitive Surgical (NASDAQ:ISRG) Shareholders Have Earned a 22% CAGR Over the Last Five Years
5 MedTech Stocks That Are Poised to Beat the Market in 2025
How Humanoid Robots and AI Will Change the Workforce
Intuitive Surgical, Inc. (ISRG) Declines More Than Market: Some Information for Investors
UBS's Global Equity Focus List: Stocks Within Health Technology
Behind the Scenes of Intuitive Surgical's Latest Options Trends
RBC Capital Maintains Intuitive Surgical(ISRG.US) With Buy Rating, Raises Target Price to $611